Groundbreaking Sound Based Technology to Ablate Renal Cancer

Dr. David Schulsinger spearheads pilot study for ablation of renal cell carcinoma with SonaCare Medical’s Sonatherm® Laparoscopic Soft Tissue HIFU Surgical Ablation Device.10/29/2014

Source: Kidney Cancer Association - October 29, 2014 Category: Cancer & Oncology Source Type: news